Ketamine and midazolam kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome

Intensive Care Medicine

Volumn 27, Issue 6, 2001, Pages 1087-1090

  Tsubo, Toshihito ^a   Sakai, Ichiro ^a   Okawa, Hirobumi ^a   Ishihara, Hironori ^a   Matsuki, Akitomo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

CHDF; Ketamine; Midazolam

Indexed keywords

DRUG METABOLITE; KETAMINE; MIDAZOLAM; NORKETAMINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; HEMODIALYSIS; HEMOFILTRATION; HUMAN; MULTIPLE ORGAN FAILURE; RATING SCALE; SEDATION; ULTRAFILTRATION;

ANALGESICS; ANTI-ANXIETY AGENTS; FEMALE; GLASGOW COMA SCALE; HEMODIAFILTRATION; HUMANS; KETAMINE; MALE; METABOLIC CLEARANCE RATE; MIDAZOLAM; MIDDLE AGED; MULTIPLE ORGAN FAILURE;

EID: 0034925469     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340100965     Document Type: Article

References (17)

1. The influence of renal failure on the kinetics of intravenous midazolam: An "in vitro" and "in vivo" study
2. Effects of enzyme induction, renal and cardiac function on ketamine plasma kinetics in patients with ketamine long-term analgosedation
3. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care
4. Progress in acute organ-system failure
5. Accurate and simplified determination of ketamine in plasma by gas chromatography mass spectrometry
6. Renal replacement therapies in pediatric multiorgan dysfunction syndrome
7. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration
8. Drug dosing adjustments during continuous renal replacement therapies
9. Pharmacokinetics in renal disease
10. Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine
11. Metabolism of ketamine stereoisomers by human liver microsomes
12. Norkertamine the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spiral cord
13. Pharmacokinetics of propofol and ketamine during and after total intravenous anesthesia with propofol, fentanyl and ketamine for pediatric patients
14. Continuous infusion of midazolam for sedation of ventilator patients
15. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients
16. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin
17. Prolonged sedation due to accumulation of conjugated metabolites of midazolam